Extracranial venous stenosis is an unlikely cause of multiple sclerosis. |
|
2010.12.06. 16:19 |
|
http://www.ncbi.nlm.nih.gov/pubmed/21041329
|
Positive Results In Randomized Withdrawal Sativex(R) Study Confirm Long Term Efficacy In MS Spasticity |
|
2009.02.26. 14:57 |
|
GW Pharmaceuticals plc (GWP:AIM) announces positive results from a placebo-controlled randomized withdrawal study of Sativex® in patients with spasticity due to Multiple Sclerosis (MS).
|
Immune Molecule Decreases Severity Of Multiple Sclerosis-like Disease In Mice |
|
2008.12.31. 14:06 |
|
ScienceDaily (Dec. 30, 2008) — A group led by Dr. Cedric Raine at Albert Einstein College of Medicine have explored the expression of an immune molecule (CXCL1) that interacts with myelin-producing cells, finding that CXCL1 decreases the severity of disease in a mouse model of multiple sclerosis (MS).
|
Biogen Says Tysabri Patient With Brain Illness Died |
|
2008.12.19. 16:38 |
|
Dec. 19 (Bloomberg) -- A multiple sclerosis patient who developed a severe brain infection after taking Biogen Idec Inc. and Elan Corp.’s Tysabri, the fourth case reported in five months, has died, according to Biogen.
|
MS drug Tysabri may promote brain infection: study |
|
2008.12.17. 13:41 |
|
WASHINGTON (Reuters) – The popular multiple sclerosis drug Tysabri appears to promote a rare brain infection by suppressing immune system cells in the brain, researchers said on Tuesday.
|
Biogen says new brain infection linked to Tysabri |
|
2008.12.16. 16:52 |
|
NEW YORK (Reuters) – Biogen Idec Inc said on Monday it notified regulators of a new case of a potentially deadly brain disease in a patient being treated with its Tysabri multiple sclerosis drug, the fourth such case reported globally this year.
|
Multiple Sclerosis - FTY720 (Fingolimod) Trial Results |
|
2008.12.16. 16:50 |
|
FTY720 (fingolimod), an experimental oral drug for relapsing MS is more effective than current treatments according to new research reported today.
|
Intraspinal Implant Of Mesenchymal Stem Cells May Not Heal The Demyelinated Spinal Cord |
|
2008.11.14. 19:14 |
|
Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord. Therapeutic hope for curing multiple sclerosis and other demyelinating diseases has included the possibility that stem cell transplants could help remyelinate the spinal cord. Accordingly, researchers from the University of Cambridge (UK) conducted experiments using animal models to see if the direct implantation of multipotent mesenchymal stem cells (MSCs) (derived from a different rat's adult bone marrow, i.e. allogenic) into the demyelinated rat spinal cord would be therapeutic and remyelinate the damaged area.
|
Interferon Treatment For MS Reduces Lesions In About Half Of Patients |
|
2008.11.14. 19:12 |
|
According to an article published early online and in the January 2009 issue of Archives of Neurology, about half of multiple sclerosis (MS) patients who are treated with three years of interferon beta are able to achieve and sustain a response as measured by regular magnetic resonance imaging (MRI) evaluations.
|
Cannabis extract did not have psychopathological or cognitive effects on MS patients in a clinical study |
|
2008.11.10. 02:16 |
|
According to a placebo-controlled clinical study conducted at the
University of Rome, Italy, the cannabis extract Sativex did not
cause psychopathological states or cognitive deficits in patients
with multiple sclerosis. In this 8-week crossover trial 17 patients
received Sativex and placebo for three weeks each.
|
Predicting Multiple Sclerosis Progression By MRI |
|
2008.11.07. 22:30 |
|
A new study published in Journal of Neuroimaging shows that MRI scans used on multiple sclerosis (MS) patients to determine if the disease has affected gray matter in the brain can identify those at-risk for progression of disability.
|
Too Much Of A Charge-Switching Enzyme Causes Symptoms Of Multiple Sclerosis And Related Disorders In Mouse Models |
|
2008.11.07. 22:29 |
|
A new study highlights the role of a charge-switching enzyme in nervous system deficits characteristic of multiple sclerosis and other related neurological illness.
|
Virtual Reality Helps MS Patients Regain Stability While Walking, Medigait LLC Claims |
|
2008.11.05. 12:34 |
|
Studies performed over the last few years show many Multiple Sclerosis (MS) patients no longer have to live with a meandering or unsteady gait caused by their disease. According to a study published in the highly acclaimed medical journal "Neurology", closed-loop visual feedback helps MS patients improve their walking. Both stride length and walking speed improved dramatically helping MS patients walk safely.
|
Biogen Says Brain Illness Found in Tysabri Patient |
|
2008.10.30. 14:17 |
|
Oct. 29 (Bloomberg) -- Biogen Idec Inc. said a patient taking its multiple sclerosis drug Tysabri was diagnosed with a life-threatening brain illness, the third case reported since July.
|
Disease diagnosis in just 15 minutes |
|
2008.10.01. 13:09 |
|
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
|
Multiple sclerosis patients have higher spinal fluid levels of suspicious immune molecule |
|
2008.09.30. 13:10 |
|
A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease.
|
Kis mennyiségben is elég a gyógyszer |
|
2008.09.28. 20:38 |
|
Őssejtes kezelés, fotoferezis, terápia: az autoimmun betegségek új kezelési lehetőségei a Debreceni Egyetemen.
|
Five Year Data Confirm That Early Treatment With Betaferon® At First Sign Of Disease Can Delay Progression To MS |
|
2008.09.27. 19:24 |
|
New data confirm that early initiation of Betaferon® (interferon beta-1b) treatment in patients with a first event suggestive of multiple sclerosis (MS) significantly delays the onset of clinically-definite MS (CDMS) by 37 percent (p=0.003) and McDonald MS by 45 percent (p<0.0001) over five years compared to delayed treatment.
|
The Majority Of Children Vaccinated Against Hepatitis B Are Not At Increased Risk Of MS |
|
2008.09.27. 19:22 |
|
The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS), according to a study to be published in the October 8, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.
|
Bayer says early Betaferon use most effective |
|
2008.09.21. 13:41 |
|
FRANKFURT (Reuters) - Bayer's multiple sclerosis (MS) treatment Betaferon was shown to be more effective when given on the first sign of the disease than if treatment is delayed, the German drugmaker said on Saturday.
|
Laquinimod Demonstrated Significant And Sustained Impact On Multiple Sclerosis Disease Activity |
|
2008.09.20. 12:32 |
|
New data from the extension phase of oral laquinimod in relapsing-remitting multiple sclerosis (RRMS) demonstrated a significant reduction in the mean number of gadolinium-enhancing (GdE) lesions in both patients who switched from placebo to laquinimod and patients who continued with their initial laquinimod dose.
|
Hadassah Hospital Study Shows That Neural Cells Derived From Human Embryonic Stem Cells Reduce Multiple Sclerosis (MS) Symptoms |
|
2008.09.09. 12:50 |
|
The Study Data Is Published in the Scientific Journal of PLoS
|
Pharmaceutical Company Confirms Two Cases Of PML In People With MS Taking Tysabri |
|
2008.08.05. 21:02 |
|
A report from Biogen Idec has confirmed two further cases of progressive multifocal leukoencephalopathy (PML) in people with multiple sclerosis (MS) in the EU.
|
Caffeine could help prevent multiple sclerosis |
|
2008.07.02. 23:58 |
|
A new study is suggesting that having several cups of coffee a day could halt the development of multiple sclerosis (MS).
|
Sikeres kísérleti őssejtterápia idegrendszeri elváltozások kezelésére |
|
2008.06.20. 01:39 |
|
Amerikai kutatók visszafordítottak egy halálos kimenetelű idegrendszeri elváltozást a betegség vizsgálatára használt egerek egy részében, az állatok gerincvelejébe történő őssejtbeültetéssel. A kísérletek sikeressége pár éven belül új terápiás lehetőséget kínálhat például a szklerózis multiplexben.
|
EXTAVIA Approved In European Union For Treatment Of Multiple Sclerosis, First In Planned Portfolio Of Therapies From Novartis |
|
2008.06.12. 22:48 |
|
The European Commission has approved Extavia® (interferon beta-1b) for the treatment of early and relapsing forms of multiple sclerosis (MS) - the first in a new portfolio of medicines from Novartis that is planned to include both established treatments and innovative therapies for patients with MS.
|
Acorda shares soar on positive drug results |
|
2008.06.12. 22:32 |
|
Acorda shares soar on positive results for multiple sclerosis drug Fampridine-SR
|
Bone marrow treatments restore nerves, expert says |
|
2008.05.07. 13:16 |
|
BETHESDA, Maryland (Reuters) - An experiment that went wrong may provide a new way to treat multiple sclerosis, a Canadian researcher said on Tuesday.
|
Prozac may help to curb disease activity in multiple sclerosis |
|
2008.05.01. 17:25 |
|
The antidepressant Prozac may help to curb disease activity in the relapsing remitting form of multiple sclerosis (MS), reveals preliminary research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry.
|
Stem-cell treatment could reverse multiple sclerosis effects ‘within 15 years’ |
|
2008.04.24. 15:07 |
|
Professor Charles ffrench-Constant said stem cells could be used to reverse the effects of multiple sclerosis
The effects of multiple sclerosis could be reversed with stem-cell treatment within 15 years, a leading expert on the disease said today.
|
Accelerated Cure Project For Multiple Sclerosis Is One Thousand Steps Closer To A Cure For MS |
|
2008.04.24. 15:04 |
|
Accelerated Cure Project for Multiple Sclerosis, a national nonprofit organization, announced that they have completed their initial drive to collect one thousand blood and data samples to build the largest openly accessible, multi-disciplinary repository ever assembled for use in Multiple Sclerosis (MS) research.
|
Genentech And Biogen Idec Announce Top-Line Results From A Phase II/III Clinical Trial Of Rituxan In Primary-Progressive Multipl |
|
2008.04.21. 13:33 |
|
Genentech, Inc. (NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BIIB) announced that a Phase II/III study of Rituxan® (rituximab) for primary-progressive multiple sclerosis (PPMS) did not meet its primary endpoint as measured by the time to confirmed disease progression during the 96-week treatment period.
|
Drug trial casts doubt over cannabis-based painkiller for MS sufferers |
|
2008.04.16. 11:40 |
|
A cannabis-based painkiller has performed little better than a dummy drug in trials, raising doubts about its effectiveness in treating multiple sclerosis.
|
Food as Medicine? |
|
2008.04.16. 11:38 |
|
Caffeine, green tea and tart cherries may guard against multiple sclerosis, cancer and cardiovascular troubles, respectively, new research suggests.
|
Caffeine prevents multiple sclerosis-like disease in mice |
|
2008.04.16. 11:37 |
|
Mice given caffeine equivalent to a human drinking six to eight cups of coffee a day were protected from developing experimental autoimmune encephalomyelitis (EAE), the animal model for the human disease Multiple Sclerosis (MS), according to researchers at Cornell University.
|
New Wesley Research Institute Study Aims To Halt The Progression Of Multiple Sclerosis |
|
2008.04.16. 11:34 |
|
A new research study being conducted at The Wesley Research Institute (WRI) aims to stop the progression of early active stage Multiple Sclerosis (MS) in its tracks.
|
Study uses hormones to treat multiple sclerosis |
|
2008.04.16. 11:32 |
|
Pregnant multiple sclerosis patients have long noticed a sharp reduction in their symptoms - only to see them reappear after giving birth.
It's what tipped off researchers to the potential power of estriol, a type of estrogen that surges during the second and third trimesters of pregnancy to help prevent the body from rejecting the fetus. But new research shows it may do much more.
|
Teva reports positive results of multiple sclerosis study |
|
2008.04.16. 11:24 |
|
Teva Pharmaceutical Industries has reported encouraging results from a three-year study evaluating relapsing-remitting multiple sclerosis patients who failed first-line monotherapy and switched treatments.
|
Potential Treatment For Multiple Sclerosis Begins Clinical Trials |
|
2008.04.16. 11:21 |
|
A potential treatment for multiple sclerosis (MS), developed by University of Greenwich in association with Kings College, London, has begun clinical trials.
|
Pluristem's PLX Cells Show a Statistically Significant Advantage in a Pre-Clinical Study in the Multiple Sclerosis Model |
|
2008.04.16. 11:18 |
|
Pluristem Therapeutics Inc. (NASDAQ:PSTI) (DAX:PJT) a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announced today that a preclinical study utilizing the Company's PLacental eXpanded (PLX) cells showed a statistically significant advantage in ameliorating functional deficiencies in a standard Multiple Sclerosis (MS) animal model. PLX cells are mesenchymal stromal cells (MSCs) obtained from the placenta and expanded using Pluristem's proprietary 3D PluriX(TM) technology.
|
Genentech, Biogen's Rituxan Medicine Fails to Slow MS |
|
2008.04.16. 11:16 |
|
Genentech Inc. and Biogen Idec Inc.'s cancer drug Rituxan failed to slow the disabling effects of the most difficult-to-treat form of multiple sclerosis in a large clinical trial.
|
Environmental factors linked to development of autoimmune diseases |
|
2008.03.31. 18:07 |
|
Scientists working at the MRC National Institute for Medical Research have shown that environmental factors can influence the development of autoimmune diseases like multiple sclerosis.
|
Potential New Target For Multiple Sclerosis Therapy |
|
2008.03.29. 12:30 |
|
ScienceDaily (Mar. 28, 2008) — Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease.
|
Szklerózis mellé halálos májkárodosás |
|
2008.03.25. 18:49 |
|
Figyelmeztetés: egy héten belül súlyos mellékhatásai lehetnek egy SM-gyógyszernek
|
Eye test peers into heat-related multiple sclerosis symptoms |
|
2008.03.22. 13:28 |
|
DALLAS – March 20, 2008 – A bodysuit that heats or cools a patient, combined with painless measurements of eye movements, is providing multiple sclerosis researchers at UT Southwestern Medical Center with a new tool to study the mysterious link between body temperature and severity of MS symptoms.
|
Peptimmune Completes Phase I Study With A Novel Peptide Copolymer For The Treatment Of Multiple Sclerosis |
|
2008.03.19. 15:19 |
|
Peptimmune, Inc. a privately held biotechnology company, announced that it has completed its first clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
|
Parents rejoice over daughter's miracle |
|
2008.03.14. 18:12 |
|
A midnight flight from Ottawa to Vancouver delivered something of a miracle to Surrey couple Jacky and Tom Telder.
|
Accentia Biopharmaceutical's Revimmune Receives the Frost & Sullivan Multiple Sclerosis Product Innovation of the Year Award |
|
2008.03.14. 18:08 |
|
TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI - News) today announced that Revimmune™, its potential blockbuster therapeutic candidate designed to treat up to 80 autoimmune diseases, has been awarded the Frost & Sullivan 2007 North American Multiple Sclerosis Product Innovation of the Year Award. If approved, Revimmune would be the first product capable of restoring neurological function in patients with relapsing-remitting multiple sclerosis (MS). Accentia intends to file an Investigational New Drug Application (IND), aiming to commence a Phase 3 MS clinical trial this year.
|
Suffering from MS, putting hope in a diet |
|
2008.03.13. 12:23 |
|
What you are about to read is not an endorsement of any particular diet as a therapy for multiple sclerosis. Nor is it a suggestion to forgo established medical treatments.
|
Sirtris Pharmaceuticals Collaborator Presents Neuroprotective Data for Oral Drug Candidate SRT501 at North American Neuro-Ophtha |
|
2008.03.11. 19:22 |
|
CAMBRDIGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT - News), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today that drug candidate SRT501, when orally administered, suppressed neurological dysfunction in a preclinical model of multiple sclerosis. Kenneth Shindler, MD, PhD, Assistant Professor of Ophthalmology at the University of Pennsylvania Scheie Eye Institute and lead investigator, will present the data today at the North American Neuro-Ophthalmology Society annual meeting.
|
Can drinking worm eggs treat MS |
|
2008.03.08. 12:36 |
|
Some UW Hospital patients will soon test an unusual treatment: They'll drink a cocktail of worm eggs, which will hatch inside their bodies.
|
Pixantrone To Be Studied In Phase I/II Trial For Aggressive Multiple Sclerosis |
|
2008.03.07. 12:38 |
|
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that its investigational drug pixantrone will be studied in a multicenter phase I/II trial initiated by the Fondation Charcot Stichting, in Brussels, Belgium, which sponsors a consortium of centers involved in studying new therapies for the treatment for multiple sclerosis.
|
Tai chi gives renewed strength to patients |
|
2008.03.05. 20:28 |
|
Dennis Johnson wobbles slightly, looking for balance as he moves himself through the paces of a super-slow Tai chi walk.
|
Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood Problems |
|
2008.03.04. 18:07 |
|
Multiple sclerosis patients who smoke marijuana in search of symptom relief are more likely to suffer cognitive shortfalls and mood disorders, new Canadian research suggests.
|
Genentech, Biogen's Rituxan Reduces Relapses of MS |
|
2008.03.04. 18:03 |
|
Genentech Inc. and Biogen Idec Inc.'s cancer drug Rituxan reduced brain lesions in multiple sclerosis patients and cut their risk of relapse, offering a potential new way to slow the disease.
|
Multiple Sclerosis: Prognosis Better Than Expected |
|
2008.03.04. 17:59 |
|
The authors evaluated data on more than 5000 patients. 60% of MS patients aged 50 years could still walk a distance of 100 meters unaided, as could 40% of patients at age 60.
|
BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board |
|
2008.03.04. 17:41 |
|
EDMONTON, March 3 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS - News), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's phase II MINDSET-01 trial of MBP8298 in patients with relapsing-remitting MS has completed a safety analysis and recommended that the trial continue as per the protocol.
|
Tysabri May Cause Liver Damage, Health Officials Say |
|
2008.02.28. 21:02 |
|
The controversial multiple sclerosis drug Tysabri can start causing liver damage within six days of the first dose, U.S. health officials said Wednesday.
|
Brain drug target discovery in MS |
|
2008.02.18. 12:52 |
|
US researchers have found two potential targets for treating multiple sclerosis after an extensive trawl through proteins in the brain.
|
Multiple Sclerosis Drug May Be Linked to Melanoma |
|
2008.02.07. 19:06 |
|
Almost immediately after a 46-year-old woman with multiple sclerosis received her first dose of the drug Tysabri, a mole that had been on her shoulder for years suddenly took on a dangerous new character.
|
Új Alzheimer-, SM- és Parkinson-terápia Izraelből? |
|
2008.01.24. 21:14 |
|
Bíztató állatkísérletek után liszensztranszfer, adásvétel a Yissum és az Eucalyptus között.
|
FDA Launches Misguided Attack on Estriol, Despite Proof it is Safe and Effective for Women, says Dr. Erika |
|
2008.01.23. 13:12 |
|
"Why would the FDA try to take estriol off the market when it is not only safe for women in menopause, it may even help women with multiple sclerosis," writes Dr Erika. Maybe it is because the agency is more concerned with protecting Wyeth than it is with protecting women, she says. Wyeth is the manufacturer of the top-selling synthetic hormone replacement therapies on the market. Earlier this month, the FDA sent warning letters to compounding pharmacies over the effectiveness of the bioidentical hormones prescribed by an increasing number of physicians. The agency also warned it is considering a ban on estriol. The FDA action was in response to a so-called "citizen's petition" sponsored by Wyeth
|
New Therapeutic Target For Treatment Of Multiple Sclerosis |
|
2008.01.23. 13:07 |
|
An international research team, led by a scientist from the Centre hospitalier de l'Universite de Montreal (CHUM), has identified new therapeutic targets for the treatment of multiple sclerosis (MS). In the February issue of Nature Immunology, the team provides fresh answers concerning the role of novel adhesion molecules in the pathogenesis of MS, a chronic autoimmune disease of the nervous system that affects approximately 55,000 young adults in Canada.
|
Genetikai tényezők a sclerosis multiplex kezelésében |
|
2008.01.17. 11:10 |
|
A scerosis multiplex kezelésében a konzervatív kezelési módszer a béta interferon terápia. Összehasonlítva azoknak a betegeknek a DNS-ét, akiknél a terápia hatékony, azokéval, akiknél eredménytelen, a kutatók jelentős eltéréseket észleltek. Így már a kezelés elkezdése előtt megjósolható a terápia eredményessége. Az ezzel foglalkozó tanulmány az 'Archives of Neurology' című szaklap márciusi számában lát majd napvilágot.
|
Nature Could Provide Cures For Autoimmune Diseases |
|
2008.01.03. 14:30 |
|
Multiple sclerosis, juvenile diabetes and rheumatoid arthritis affect millions of Americans, yet doctors still aren't sure what causes autoimmune diseases. But researchers are hopeful nature could provide some help.
|
Blood-brain Barrier: A Misunderstood Key To Finding Life-saving Cures To Brain Disease |
|
2007.12.19. 19:05 |
|
ScienceDaily (Dec. 18, 2007) — An international team of scientists that includes a Saint Louis University researcher suggest several strategies to propel research for treatments of brain diseases that include multiple sclerosis, Alzheimer's disease, obesity and stroke in the January issue of the Lancet Neurology.
|
Xanthus' Symadex Demonstrates Ability to Increase Spinal Cord Remyelination in Multiple Sclerosis Model |
|
2007.12.18. 12:15 |
|
Preclinical data presented at a meeting of the Multiple Sclerosis Society of Canada
|
BioMS Medical's Phase III U.S. Multiple Sclerosis Trial Receives Positive Safety Review From Data Safety Monitoring Board |
|
2007.12.18. 12:13 |
|
BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.
|
Combination therapy including antibiotics may be beneficial for multiple sclerosis |
|
2007.12.18. 12:10 |
|
A preliminary study suggests that combining a medication currently used to treat multiple sclerosis with an antibiotic may slow the progress of the disease, according to an article posted online today that will appear in the February 2008 print issue of Archives of Neurology.
|
Antibiotikum SM kezeléséhez |
|
2007.12.14. 21:57 |
|
Egy bevezető tanulmány szerint, ha a sclerosis multiplex kezelésére jelenleg használt gyógyszert, kombinálják egy antibiotikummal, lelassítja a betegség lefolyását. A tanulmány az Archive of Neurology-ban jelent meg.
|
Sugárkezelés nélkül újjáépíthető az immunrendszer |
|
2007.11.24. 20:10 |
|
A csontvelőbe ültetett őssejtek segítségével amerikai tudósok egereket tettek képessé saját immunrendszerük újjáépítésére.
|
Teva begins enrolment in phase III study of oral laquinimod |
|
2007.11.12. 12:42 |
|
Teva Pharmaceutical Industries Ltd. and Active Biotech AB has announced the initiation of enrolment in the Allegro trial (assessment of oral laquinimod in preventing progression of multiple sclerosis).
|
Anti-inflammation Molecule Helps Fight MS-like Disease, Study Suggests |
|
2007.11.12. 12:41 |
|
ScienceDaily (Nov. 12, 2007) — An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.
|
Blood pressure drug hope for MS |
|
2007.11.12. 12:36 |
|
A drug which has been used for decades to treat high blood pressure may turn out to be a key treatment for multiple sclerosis, say British researchers.
|
Őssejtekkel a szklerózis ellen |
|
2007.11.07. 14:24 |
|
A szklerózis multiplex az idegrendszer idült, gyulladásos betegsége. Okát még ma sem tudják pontosan, noha kifejlődési mechanizmusa már részlegesen ismert. A ma még gyógyíthatatlannak számító betegséget Baselben őssejt-terápiával kezelték egy fiatal lányon, akinek állapota azóta javult.
|
Study Shows Antibiotic Harms ALS Patients |
|
2007.11.03. 12:15 |
|
Researchers hoped minocycline might have helped those with Lou Gehrig's disease.
|
New Causes For Neurodegeneration Discovered By U-M Scientists |
|
2007.10.28. 13:58 |
|
Diseases that cause neurons to break-down, such as Alzheimer's, Multiple Sclerosis and Creutzfeldt-Jakob disease (Mad Cow Disease), continue to be elusive to scientists and resistant to treatments.
|
DNS oltás után megváltozik a sclerosis multiplex lefolyása |
|
2007.10.26. 17:03 |
|
Egy újonnan kifejlesztett DNS oltás képes alapvetően megváltoztatni a betegség lefolyását azoknál a pácienseknél, akiknél a sclerosis multiplex (SM) klinikumát relapsusok és remissziók jellemzik.
|
Common antibiotic tested as treatment for multiple sclerosis |
|
2007.10.26. 16:55 |
|
An old-fashioned, inexpensive antibiotic commonly used to clear up pimply faces and bacterial infections is about to be put to the test against multiple sclerosis.
|
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis |
|
2007.10.25. 14:13 |
|
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA - News), a company involved in the development and commercialization of cell therapies, today provided an update on its 150-patient Phase IIb safety and efficacy study (TERMS) of Tovaxin® in multiple sclerosis. The trial design is a U.S. multicenter, randomized, double-blind, placebo-controlled study of subcutaneous Tovaxin in subjects with Clinically Isolated Syndrome (CIS) or Relapsing/Remitting Multiple Sclerosis (RRMS).
|
Antisense Therapeutics Releases ATL1102 Phase IIa Multiple Sclerosis Trial Update |
|
2007.10.25. 14:12 |
|
Antisense Therapeutics released an update on its ATL1102 Phase IIa Multiple Sclerosis clinical trial it is currently conducting in Europe.
|
Researchers Find Important Clue To Immune Infertility |
|
2007.10.25. 14:10 |
|
Most of us have never heard of immune infertility, yet it prevents many prospective parents from conceiving.
|
Disease activity increases after multiple sclerosis patients stop natalizumab |
|
2007.10.25. 14:08 |
|
People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity, according to a study published September 12, 2007, in the online edition of Neurology, the medical journal of the American Academy of Neurology.
|
Gene Logic Identifies Gene Expression Patterns Associated with Multiple Sclerosis in Blood Cells |
|
2007.10.25. 13:53 |
|
Company Is Collaborating with Accelerated Cure Project for Follow-On Studies Using Blood Samples
|
Multiple Sclerosis Nerve Damage Repaired By Scientists |
|
2007.10.10. 18:21 |
|
Nerve damage which was caused by multiple sclerosis (MS) was repaired by scientists from the Mayo Clinic, Rochester, USA, who were working with mice. The scientists said it is hoped this may lead the way to new treatments for humans.
|
Smoking Has No Effect On Progression Of Multiple Sclerosis, Study Suggests |
|
2007.10.10. 18:18 |
|
Contrary to an earlier report, smoking appears to have no effect on the progression of multiple sclerosis (MS), according to a new study.
|
Peptimmune Initiates Phase I Study With A Novel Peptide Copolymer For The Treatment Of Multiple Sclerosis |
|
2007.10.05. 11:34 |
|
Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PI-2301, a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
|
Megint többet sejtünk a szklerózis multiplex kialakulásáról |
|
2007.10.02. 08:28 |
|
A neurofascin fehérje elleni antitest kulcsszerepet játszhat a szklerózis multiplex (SM) kialakulásában - derül ki a müncheni Ludwig-Maximilian Egyetem és a Max-Planck-Intézet martinsriedi neurobiológiai kutatóközpontjának tanulmányából.
|
Preclinical Study Published in Nature Medicine Shows Anti-LINGO-1 Antibody Promotes Remyelination |
|
2007.10.01. 16:14 |
|
Suggests Potential Role in the Treatment of Multiple Sclerosis and Other Demyelinating Diseases
|
Study of bone marrow stem cells in multiple sclerosis |
|
2007.09.27. 13:41 |
|
A new pilot clinical trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis has started at Frenchay Hospital. The aim of the trial, conducted by the University of Bristol and North Bristol NHS Trust, is to find out what effects, good or bad, it has on patients with MS, and their disability.
|
Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens |
|
2007.09.26. 15:42 |
|
MS sufferers, who have found little benefit from drug treatments, are finding success in a diet that targets five food triggers. Sugar and saturated fats also contribute to the disease process. By identifying and eliminating food sensitivities, along with other simple dietary changes, the MS Recovery Diet can halt and reverse symptoms for those afflicted with MS.
|
New imaging technique allows doctors to 'see' molecular activity |
|
2007.09.25. 13:58 |
|
A new technique that will enable doctors to ‘see’ things happening at the molecular level using standard imaging techniques has been developed by Oxford scientists. The technique has initially been directed towards multiple sclerosis, but long-term it has the potential to be used for a vast range of health problems. The findings are published by Nature Medicine on Monday 24 September.
|
Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients |
|
2007.09.22. 12:33 |
|
Study also suggests treatment for short-term and long-term damage caused by chronic disease
|
Hollis-Eden reports promising results for multiple sclerosis treatment |
|
2007.09.19. 18:00 |
|
Hollis-Eden Pharmaceuticals has announced new data showing that its pre-clinical drug candidate provides benefit in an animal model of multiple sclerosis.
|
Kingfisher Healthcare Launches Breakthrough Product in Europe |
|
2007.09.19. 17:32 |
|
LEUVEN, Belgium, September 19 /PRNewswire/ -- Kingfisher Healthcare (KFH) announces the launch of KFH Energy, a product to alleviate fatigue and pain, two common problems associated with chronic diseases such as post polio syndrome, fibromyalgia and multiple sclerosis. KFH Energy is a patented, high-tech medical device for home use.
|
Hookworms May Treat Asthma And Other Allergies By Impacting On The Immune System |
|
2007.09.16. 13:04 |
|
Researchers in the UK are eager to find out whether blood-sucking worms - hookworms - might have an effect on the immune system and be used for effective treatment for asthma and other allergies. Researchers from the University of Nottingham say these worms may even have therapeutic benefits for patients with diabetes type 1 and multiple sclerosis.
|
Őssejtkapszulák: megszólalt az érintett |
|
2007.09.09. 19:31 |
|
A Pécsett indult rendőrségi vizsgálat még nem ért finisébe, az őssejt kapszulákat továbbra is kínálják.
|
Új remény a szklerózis multiplex kezelésében |
|
2007.09.02. 10:23 |
|
Magyarországon 6-8 ezer szklerózis multiplexben szenvedő beteg él, nagy részük előbb-utóbb mozgássérültté válik. A Pécsi Tudományegyetem Neurológiai Klinikájának tanszékvezetője az InfoRádiónak elmondta: a legújabb kutatások már nemcsak a betegség előrehaladásának lassítását célozzák, hanem a kialakult sérülések visszafordítását is lehetővé tehetik.
|
Promising DNA Vaccine For Multiple Sclerosis |
|
2007.08.14. 16:02 |
|
A new DNA vaccine may be helpful for those who suffer from multiple sclerosis (MS), according to an article in this week's online issue of Archives of Neurology (JAMA/Archives). The article explains that the vaccine works on the brain and immune system.
|
Drug's trials are just a start |
|
2007.07.20. 14:10 |
|
Scientists at Oregon Health & Science University have begun the first stage of clinical trials for a new drug they say has the potential to be a breakthrough treatment for people suffering from multiple sclerosis.
|
Oral TRIMESTA Initiates Dosing in Phase II/III Clinical Trial |
|
2007.07.17. 13:24 |
|
Pipex Pharmaceuticals' Oral TRIMESTA Initiates Dosing in Phase II/III Clinical Trial for Multiple Sclerosis
|
MS drug minus side effects |
|
2007.07.14. 14:04 |
|
BIONOMICS has discovered a promising multiple sclerosis treatment, which appears to lack the side effects associated with current medicines.
|
New Clue Why MS Affects African Americans Differently Than Caucasians |
|
2007.07.05. 14:29 |
|
Differences in immune systems have been found in African Americans with multiple sclerosis (MS) compared to Caucasians, possibly offering a clue why African Americans experience more disability with MS than Caucasians, according to a study published in the July 3, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.
|
Quebec man with multiple sclerosis misdiagnosed as insane 14 years ago |
|
2007.07.03. 16:56 |
|
A Quebec man, once diagnosed as insane by a neurologist, has actually been suffering from the effects of multiple sclerosis. - bár ez inkább az Őrület menüpontba illene...
|
EU recommends Rebif new formulation for MS patients |
|
2007.07.02. 15:53 |
|
Merck KGaA announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending marketing authorization of a new formulation of Rebif (interferon beta-1a) for the treatment of relapsing multiple sclerosis (MS).
|
Calcium ions may play key role in MS |
|
2007.06.28. 18:58 |
|
U.S. medical researchers have determined calcium ions might play a key role in multiple sclerosis by activating enzymes that degrade myelin sheaths.
|
Merck KGaA receives EMEA recommendation of new Rebif formula to treat MS |
|
2007.06.28. 18:56 |
|
The CHMP's recommendation will now be considered by the EU Commission, which will deliver the final decision on the granting of the market authorization.
|
Forradalmian új módszer az őssejtkutatásban |
|
2007.06.28. 13:57 |
|
Jelentősen felgyorsíthatja az őssejtkutatást, és új gyógymódok kidolgozását, hogy brit tudósok új típusú őssejtet találtak a kísérletekhez. A Nature-ben két tanulmány is megjelent, amelyek szerint a rágcsálóembriókból nyert őssejtek a kutatásokban helyettesíthetik emberi megfelelőiket.
|
New Line Of Communication Between Nervous System Cells Discovered |
|
2007.06.27. 14:30 |
|
In a host of neurological diseases, including multiple sclerosis (MS) and several neuropathies, the protective covering surrounding the nerves -- an insulating material called myelin -- is damaged. Scientists at the Weizmann Institute of Science have now discovered an important new line of communication between nervous system cells that is crucial to the development of myelinated nerves -- a discovery that may aid in restoring the normal function of the affected nerve fibers.
|
Mutliple Sclerosis - AnaSpec Introduces New Anti-MOG (35-55) Antibody |
|
2007.06.27. 14:27 |
|
Leveraging its portfolio of MOG (35-55) and other multiple sclerosis (MS) experimental autoimmune encephalomyelitis (EAE)-related peptides, AnaSpec has introduced its new Rabbit Anti-MOG (35-55) antibody.
|
Possible Target Of Immune Attack In MS And New Therapeutic Approach Identified By National MS Society-Sponsored Investigators |
|
2007.06.20. 19:38 |
|
A new study by National MS Society-supported researchers suggests a small protein (alpha B-crystallin) normally produced by cells to protect against injury may itself be the target of the multiple sclerosis immune attack.
|
Pipex trials menopause drug in MS |
|
2007.06.13. 13:35 |
|
Pipex Pharmaceuticals has started a phase II/III trial for Trimesta, a drug approved to treat post-menopausal hot flushes, in the treatment of women with relapsing-remitting multiple sclerosis.
|
Cells Made to Mimic Stem Cells |
|
2007.06.11. 12:56 |
|
In a big step toward a long-sought goal, three teams of scientists say they've produced the equivalent of embryonic stem cells, at least in mice, without taking the controversial step of destroying embryos.
|
Study shows sugar supplement may treat immune disease |
|
2007.06.10. 21:48 |
|
A sugar supplement may treat immune disease by sweetening the overactive immune cells responsible for autoimmune diseases such as multiple sclerosis (MS) and type 1 diabetes and stopping them attacking the body's tissues, a study shows.
|
Idegsejtregeneráció |
|
2007.05.29. 13:34 |
|
A központi idegrendszer sejtjei - az őket ért trauma után - nem képesek regenerálódni, s ennek pontos okát az orvosok ma még nem ismerik. Azonban egyre több - az idegsejteket működésre stimuláló - eljárással kísérleteznek világszerte - olvasható a Miami Egyetem honlapján.
|
New Neurons in Old Brains Exhibit Babylike Plasticity |
|
2007.05.24. 13:16 |
|
Study finds a window of adaptability in newly formed brain cells; may lead to stem cell therapies for neurodegenerative disorders
|
Hamarosan kapható a különleges magyar készítmény – Új utakat nyithat meg az Olympiq |
|
2007.05.22. 22:21 |
|
Az elmúlt néhány év kutatásai alapján bizonyossággal kijelenthető, hogy az őssejtek szervezetünk "mindenhatói”. Bizonyítást nyert, hogy az őssejtek – a vérbe kerülve – képesek a test károsodott vagy beteg részeire eljutni és ott épp szövetsejtekké alakulni. Az őssejtterápiákról már számos alkalommal beszámolt a világ- és a magyar sajtó is; a milliókat felemésztő külföldi kezelések azonban várhatóan kiválthatóak lesznek egy szenzációnak számító hazai fejlesztéssel. Egy magyar kutatócsoport ugyanis kidolgozott egy olyan kapszulát, amely elősegíti az őssejttermelést a szervezetben, s ezáltal még nagyobb hatékonysággal lesznek megelőzhetőek és kiküszöbölhetőek a különböző betegségek. A kutatás vezetője azonban figyelmeztet: kétségtelenül nagy lehetőségek rejlenek az Olympiq néven a közeljövőben forgalomba kerülő készítményben, de a kapszula nem csodaszer, csupán egy étrend-kiegészítő.
|
Natural immune-control system may aid treatment of autoimmune disease and tissue rejection |
|
2007.05.21. 14:48 |
|
The immune system's ability to police itself may offer a new method of arresting the cells responsible for autoimmune diseases such as multiple sclerosis and for the rejection of transplanted organs and tissues, scientists at Dana-Farber Cancer Institute report in a study in the May issue of the journal Immunity.
|
Genzyme gets OK to resume testing of MS drug |
|
2007.05.17. 23:13 |
|
Patient in trial died of bleeding in the brain.The Food and Drug Administration will allow Genzyme Corp. to continue human tests of a new multiple sclerosis drug that caused a fatal bleeding disease in one trial patient, the company said yesterday.
|
Glucosamine-like Supplement Inhibits Multiple Sclerosis, Type 1 Diabetes |
|
2007.05.15. 14:59 |
|
A glucosamine-like dietary supplement has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type 1 diabetes mellitus, according to University of California, Irvine health sciences researchers.
|
Testosterone May Benefit Men With Multiple Sclerosis |
|
2007.05.15. 14:52 |
|
Testosterone gel may slow the progression of multiple sclerosis in men with the disease, a new study suggests.
|
Potential therapeutic target for multiple sclerosis |
|
2007.04.25. 12:57 |
|
Oregon Health & Science University neuroscientists are eyeing a protein as a potential therapeutic target for multiple sclerosis because de-activating it protects nerve fibers from damage.
|
BioMS Medical Announces Lead Investigator In United States Phase III Multiple Sclerosis Trial |
|
2007.04.21. 14:53 |
|
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), is pleased to announce Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company's pivotal phase III clinical trial of its lead drug, MBP8298, for the treatment of secondary progressive multiple sclerosis.
|
New Imaging Approach Promises Insights Into Multiple Sclerosis |
|
2007.04.18. 14:56 |
|
Science Daily — Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.
|
Nutra Pharma Announces ReceptoPharm Patent for a Method of Treating Multiple Sclerosis |
|
2007.04.12. 16:53 |
|
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its drug discovery division, ReceptoPharm, has filed a patent for a method of treating autoimmune diseases, including Multiple Sclerosis (MS) and Rheumatoid Arthritis.
|
Jefferson Immunology Researchers Show Blood-brain Barrier Damage Could Affect MS Severity |
|
2007.04.12. 16:50 |
|
Immunology researchers at the Kimmel Cancer Center at Jefferson studying a multiple sclerosis (MS)-like disease in mice have shown that the amount of "damage" to the central nervous system's protective blood-brain barrier - in essence, opening it - almost always correlates to the severity of the disease.
|
Modified bone marrow cells can help recovery in an animal model of multiple sclerosis |
|
2007.04.10. 13:31 |
|
A new study published in PLoS Medicine has shown that modified bone marrow cells can help recovery in an animal model of multiple sclerosis (MS). Harald Neumann and colleagues from the University of Bonn modified myeloid precursor cells to express a protein (triggering receptor expressed on myeloid cells-2 (TREM2), which is normally made by microglia - a cell from the nervous system - and injected these TREM2-expressing cells into the veins of mice with experimental autoimmune encephalomyelitis (EAE, an animal model of MS).
|
MultiCell enters supply agreement with Italian drug manufacturer |
|
2007.04.10. 13:30 |
|
MultiCell Technologies Inc. (OTCBB: MCET - news) has entered into a long-term agreement with Lundbeck Pharmaceuticals Italy S.p.A. for the supply of one of the active components of MCT-125, MultiCell's Phase IIb drug for the treatment of chronic fatigue in patients with multiple sclerosis.
|
Research, not rhetoric: Marijuana can save lives |
|
2007.03.05. 23:14 |
|
As Illinois legislators prepare to debate a new, practical plan for legalizing the medical use of marijuana (the Legislature actually passed a medical marijuana bill in 1971 but that flawed measure was never put into practice), they should consider a new study, published in the journal Neurology last month.
|
Receptorok és ligandok támadása |
|
2007.03.03. 22:35 |
|
Október 15–19. között Japánban, Nagoyában tartották a nyolcadik Nemzetközi Neuroimmunológiai Kongresszust. A kétévente megrendezett találkozó a kísérletes és klinikai neuroimmunológia legnagyobb rendezvénye.
|
Natural, soy-based substance might help fight MS, Jefferson neuroscientists find |
|
2006.12.12. 15:02 |
|
A natural substance made from soy appears to have amazing restorative powers when given to animals with a multiple sclerosis (MS)-like disease.
|
Gyógyító műkromoszóma |
|
2006.12.03. 22:01 |
|
A magyar tudomány egyik sikertörténete a mesterséges kromoszóma létrehozásával kezdődött: az MTA Szegedi Biológiai Központjának (SZBK) genetikai intézetében - egy tízéves kutatási program eredményeként - 1996-ra kidolgozták az élő sejtekben történő célirányos kromoszómaépítés módszerét.
|
Mintha részegek lennének - Az SM kezelése |
|
2006.11.08. 21:44 |
|
Csaknem három millió embertársunkat érinti a földünkön a központi idegrendszer gyulladása, a Sclerózis Multiplex. Addig, amíg nem szembesülünk a valóságban e betegséggel, leginkább az előítéleteink szerint tekintünk az olyanokra, akik bizonytalan járásuk miatt úgy néznek ki, "mintha részegek lennének".
|
Researchers Closer To Cure For Multiple Sclerosis And Other Myelin-related Diseases |
|
2006.11.07. 21:44 |
|
A breakthrough finding on the mechanism of myelin formation by Jonah Chan, assistant professor of cell and neurobiology at the Keck School of Medicine of the University of Southern California, could have a major impact on the treatment of diseases such as multiple sclerosis and demyelination as a result of spinal cord injuries.
|
A szklerózis multiplex tüneteit enyhítõ gént fedeztek fel |
|
2006.10.02. 12:13 |
|
Egy kutatócsoport olyan gént fedezett fel, mely mérsékelheti a szklerózis multiplex (SM) tüneteit
|
Csak óvatosan az őssejt kezelésekkel! |
|
2006.08.31. 13:59 |
|
Óvatosságra intik a szakértők azokat a pácienseket, akik előjegyezték magukat az úgynevezett őssejt "csodakúrákra".
|
'Miami snakeman' is 95 and still injects himself with venom |
|
2006.08.03. 20:36 |
|
King cobras. Green mambas. Palm vipers. Name a deadly snake and Bill Haast has either tamed it or been bitten by it.
|
Medical Cannabis Is A Blunt Tool |
|
2006.07.28. 15:10 |
|
IF anecdotes and ancient medicine are to be trusted, cannabis is a wonder drug. Yet results of clinical trials have been mixed and its use in modern medicine remains limited. Now it seems the reasons may be practical as much as political and cultural: there are fundamental problems with how our bodies respond to the stuff.
|
Őssejtkúra klinikai próbán |
|
2006.07.21. 11:51 |
|
Az utóbbi évek legtöbb vitát és reménykedést kiváltó újdonsága, az embrionális őssejtterápia hamarosan igazolja, vagy éppen cáfolja a hozzá fűzött várakozásokat. A humán embrionális őssejteket nyolc éve szaporították először sikeresen laboratóriumban. Azóta kimeríthetetlen és mindenre képes potenciális gyógyító forrásként kezeli a kutatók és a gyógyulni vágyók tömege. Ugyanakkor sokan etikai okból támadták már a felvetést is, hogy embriókból származó sejtek tenyésztésével kísérletezzenek.
|
Nutra Pharma Reports Preclinical Results Of RPI-78M To Be Presented At Scientific Meeting |
|
2006.02.15. 17:45 |
|
Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that owns rights to intellectual property related to the development of drugs for HIV and Multiple Sclerosis, has announced that the studies using RPI-78M in an animal model of Multiple Sclerosis (MS) have been accepted for presentation and publication. RPI-78M is the lead drug candidate of Nutra Pharma's holding, ReceptoPharm, Inc. and is being studied in preclinical assays for its efficacy in treating MS.
|
Xanthus' Symadex(TM) shows Remyelination in Multiple Sclerosis Animal Model |
|
2006.02.15. 17:42 |
|
CAMBRIDGE, Mass., Feb. 13 /CNW/ -- Xanthus Life Sciences, Inc., today announced that data from a study conducted with a Multiple Sclerosis (MS) animal model demonstrated that Symadex(TM) permitted remyelination by prevention of inflammatory cell infiltration. Stephen J. Karlik, Ph.D., Professor of Diagnostic Radiology at the University of Western Ontario, London, Ontario presented the research findings on February 10, 2006 at the International Workshop on Myelin Imaging, in Vancouver.
|
Cannabis a kövérség és a csontritkulás ellen |
|
2006.01.22. 20:50 |
|
A brit Royal College of Physicians orvosi szervezet kutatói az étvágytalanság, a krónikus fájdalom, a kövérség, a szívpanaszok és a csontritkulás kezelését nevezték meg a cannabis potenciális felhasználási területeként.
|
Biogenerikus szerek |
|
2005.11.07. 16:51 |
|
A hagyományos gyógyszerek piacán a generikus készítmények igen széles körben elterjedtek. Ezek tulajdonképpen egy bevált gyógyszer kis eltéréssel lemásolt hatóanyagával készülnek. Ilyen például az Aspirin generikus változata a Kalmopirin. Amikor megjelentek azok a fehérjék, amelyeket gyógyszerként lehetett alkalmazni, senki sem gondolta volna, hogy ezeket a rendkívül bonyolult molekulákat valaki képes lesz lemásolni, sőt oly módon, hogy ne legyen teljes az egyezés, hiszen az a hatóanyagok szabadalmait sértette volna.
|
Mustgázmérgezések Magyarországon - KRONOLÓGIA |
|
2005.10.30. 11:18 |
|
2005. október 28., péntek (MTI) - Mustgázmérgezés következtében meghalt egy 55 éves nő Gyöngyösön.
|
This Drug Could Help MS Victims . . . But They Can't Get It Lack of Profit Puts Off Trials |
|
2005.10.18. 19:55 |
|
SIX months ago, multiple sclerosis sufferer Neil Lucas was finding it increasingly difficult to cope with everyday life. He had problems walking and writing and had little energy.
|
Nem korfüggő a szklerózis multiplex |
|
2005.09.10. 23:54 |
|
Az eddigi elméletekkel ellentétben, a The Lancet Neurology magazinban megjelent tanulmány szerint a szklerózis multiplex kialakulásának kockázata nem múlik a gyermekek születésének sorrendjén.
|
Spanish scientists develop a cellular therapy for rheumatoid arthritis and multiple sclerosis |
|
2005.09.10. 23:52 |
|
A research team at the Institute of Parasitology and Biomedicine of the Spanish National Research Council (CSIC), in Grenade, has successfully developed in mice a cellular therapy for two major autoimmune diseases: rheumatoid arthritis and multiple sclerosis.
|
Biogen Idec Aims to Resume Sale of MS Drug |
|
2005.09.04. 20:35 |
|
Biogen Idec Seeks to Resume Sale of MS Drug With Additional Warning Label, CEO Tells AP
|
MS Drug Maker to Ask for Warning Label |
|
2005.09.04. 20:33 |
|
The company that makes a multiple sclerosis drug linked to an often-fatal brain disease will be asking U.S. regulators to allow the drug back on the market with additional warning labels.
|
IBD Linked to Risk of Multiple Sclerosis |
|
2005.09.04. 20:29 |
|
Studies Show Greater Risk of Autoimmune Disorders for People with Inflammatory Bowel Disease
|
Scientists Discover The Molecular Switch For Nerve Cells' Insulating Jelly Rolls |
|
2005.09.04. 19:59 |
|
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system. The study, published in the September 1, 2005, issue of the journal Neuron, may provide a new avenue for treating nervous system diseases such as multiple sclerosis, which are associated with damage to myelin.
|
Aspartame Reactions: a Hidden Epidemic |
|
2005.09.04. 19:11 |
|
Aspartame has been linked to a host of devastating central nervous system disorders
|
Researchers Report That Cell Transplants Protect Brain Tissues... |
|
2005.07.17. 21:24 |
|
...By Fighting Immune Attack In Mice With MS-Like Disease
|
Millennium Initiates Phase II Clinical Trial in Patients With Multiple Sclerosis |
|
2005.07.12. 16:20 |
|
MLN1202 Novel Molecule Believed to be First CCR2 Antagonist Studied in MS
|
A positive thought a day keeps the doctor away |
|
2005.07.05. 21:45 |
|
About 10 years ago I went to a medical meeting sponsored by Harvard in Boston. One lecturer gave a talk on optimism. He quoted a double blind study of more than 10,000 cases, so the results were certainly legitimate.
|
Scientists Identify Molecular Signals Affecting Myelin Repair In Multiple Sclerosis |
|
2005.07.05. 21:37 |
|
A collaboration of five of the world's leading neuroscientists, including Robert Miller, Ph.D., professor of neurosciences at the Case Western Reserve University School of Medicine, has identified three new "switches," or signals, operating in the brain and spinal column that appear to turn on and off the nerve cell's ability to repair myelin. Myelin is the protective coating surrounding nerve cells that is damaged by multiple sclerosis (MS). The scientists' findings are a critical first step in understanding myelin repair and its role in treatments for MS and other demyelinating diseases.
|
Mutliple Sclerosis - FTY720, a novel once-daily oral medication, shows promising results |
|
2005.06.26. 15:42 |
|
Phase II data presented today at the 15th European Neurological Society (ENS) meeting in Vienna showed that FTY720, a novel oral medication for the treatment of multiple sclerosis (MS), reduced the rate of clinical relapses by more than 50% and inflammatory disease activity as measured by magnetic resonance imaging (MRI) by up to 80% over six months compared to placebo.
|
FOXP3 As the Gene Marker for Impaired Immune Regulation in Multiple Sclerosis |
|
2005.06.15. 21:46 |
|
The Immune Response Corporation and Oregon Health & Science University Collaboration Identifies FOXP3 As the Gene Marker for Impaired Immune Regulation in Multiple Sclerosis; Results May Lead to a New Therapeutic Approach to Treating MS
|
PharmaFrontiers Announces Positive Interim Results of Two Phase I/II Clinical Trials for Multiple Sclerosis |
|
2005.06.03. 20:09 |
|
THE WOODLANDS, Texas--(BUSINESS WIRE)--June 3, 2005--PharmaFrontiers Corp. (OTCBB:PFTR - News), a company involved in the development and commercialization of cell therapies, announced that interim results of Tovaxin(TM) in two Multiple Sclerosis (MS) Phase I/II open-label studies indicated that it was safe and well tolerated, and patients showed positive responses. All patients enrolled in the studies had received prior standard of care therapy for MS and were in the relapsing remitting or secondary progressive stages of MS.
|
Boston Herald - Biogen learns MS's Lingo |
|
2005.05.18. 20:53 |
|
Biogen Idec Inc. scientists have identified a molecule in the central nervous system that could point the way to repairing nerves damaged by multiple sclerosis - and ultimately to regenerating injured spinal cords, the Cambridge company said yesterday.
|
Cseppekben adagolt remény |
|
2005.05.16. 13:10 |
|
Aligha van Magyarországon olyan rákos beteg, aki ne hallott volna a Béres-cseppről. Van, aki hisz benne, s van, aki nem. Ami viszont tény, a Béres József által kikísérletezett készítmény ma az ország egyik legsikeresebb gyógyszere, sok rákos beteg utolsó reménye. A most nyolcvanöt éves kutató ma is mindennap bejár az egykori kisvárdai agrárkutató intézeti szobájába. Újból nagy fába vágta a fejszéjét: a ma még gyógyíthatatlannak tartott sclerosis multiplex gyógyszerén töri a fejét.
|
New hope for MS patients |
|
2005.05.06. 21:02 |
|
There is new hope for multiple sclerosis patients. Right now, there is no drug targeted to stop the memory loss many patients with MS have.
|
Acorda Therapeutics Announces Agreement with FDA on Special Protocol Assessment for Phase 3 Clinical Trial of Fampridine-SR in M |
|
2005.05.05. 23:17 |
|
HAWTHORNE, N.Y.--(BUSINESS WIRE)--May 4, 2005--Acorda Therapeutics announced today that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment for a pivotal, Phase 3 clinical trial of Fampridine-SR in multiple sclerosis (MS). A Special Protocol Assessment (SPA) is a process in which the FDA provides evaluation and guidance on clinical trial protocols for Phase 3 studies.
|
Irish firm may return drug to market |
|
2005.04.29. 13:03 |
|
DUBLIN Elan, the Irish drugmaker that has lost more than 80 percent of its value since it withdrew a promising multiple sclerosis treatment in February, is optimistic that the drug will be in use again by the end of the year, Kelly Martin, its chief executive, said Thursday.
|
PRYOR THANKFUL FOR MULTIPLE SCLEROSIS |
|
2005.04.28. 18:02 |
|
Comedian RICHARD PRYOR claims multiple sclerosis has had a positive effect on his life, because it ended a downward spiral further into drug addiction.
|
Ginkgo beneficial for multiple sclerosis symptoms, OHSU study |
|
2005.04.28. 17:59 |
|
When it comes to her health, Janice Winfield of Portland, Ore., does her research.
|
Acorda launches spasticity capsules |
|
2005.04.28. 00:09 |
|
Acorda Therapeutics has launched Zanaflex Capsules, a new capsule formulation of tizanidine, a leading treatment for spasticity in multiple sclerosis and spinal cord injury in the US.
|
Scientists trial new MS drug treatment |
|
2005.04.28. 00:04 |
|
Australian scientists have developed a novel new treatment for multiple sclerosis (MS), with the hope the new drug may work for those patients who are not helped by existing treatments.
|
Diabetes drug might help with MS |
|
2005.04.28. 00:02 |
|
For the 350,000 Americans who suffer from multiple sclerosis – a disease that strikes women twice as often as men – a common diabetes drug could be the latest breakthrough treatment.
|
Aszpirin fáradékonyság ellen? |
|
2005.04.28. 00:01 |
|
Drugs such as modafinil (an agent promoting wakefulness) are used to try to counteract the fatigue of multiple sclerosis (MS), but evidence for their efficacy is scant. A randomised, placebo controlled, double blind study of modafinil including 115 patients found no improvement after five weeks ( Neurology 2005;64: 1139-43[Abstract/Free Full Text]), although a randomised controlled crossover trial of aspirin in 30 patients with MS published in the same issue (1267-9) shows that the drug alleviated the problem. The authors propose that aspirin may work by blocking the output of the hypothalamus, which in turn affects the neuroendocrine and autonomic responses important in the perception of fatigue.
|
Canada approves pot-like painkiller |
|
2005.04.27. 23:56 |
|
Sativex, which dulls neuropathic pain without giving off a high, could hit stores by summer.
|
Mechanisms by which neurons are damaged in multiple sclerosis |
|
2005.04.27. 23:52 |
|
Two studies reported on mechanisms by which neurons are damaged in multiple sclerosis (MS). Researchers in Germany and New York showed that when immune cells destroy the insulating myelin around neurons, a molecule called 7-ketocholesterol is released.
|
Smoking Tied to Multiple Sclerosis Progression |
|
2005.04.27. 23:51 |
|
Cigarette smoking has already been identified as a risk factor for multiple sclerosis (MS). Now new research for the first time also implicates smoking in the progression of the degenerative disease.
|
mcall.com - Vitamin D is not just for bones anymore |
|
2005.04.26. 15:12 |
|
We've long known the benefits of vitamin D for strengthening bones, but researchers are finding that it may also play a role in preventing heart disease, certain types of cancer, arthritis and autoimmune diseases such as multiple sclerosis.
|
WTNH.com - New trial to help MS patients stay mobile |
|
2005.04.26. 15:11 |
|
(WTNH, Apr. 25, 2005 5:30 PM) _ In many cases Multiple Sclerosis takes away the ability to walk. So far no drug has been able to help. Now, researchers say robotic technology could be the answer.
|
India Daily - Promising Multiple Sclerosis treatments on the way |
|
2005.04.14. 13:28 |
|
The suspension of sales of promising multiple sclerosis drug Tysabri earlier this year was devastating to disease sufferers, but it has opened a window of opportunity to alternative treatments.
|
medicalnewstoday - COPAXONE(R) Only MS Therapy Available Without Warnings or Precautions for Liver Damage |
|
2005.03.22. 20:34 |
|
20 Mar 2005
|
canada.com - GlaxoSmithKline says FDA has halted trials of multiple sclerosis drug |
|
2005.03.22. 20:32 |
|
Sunday, March 20, 2005
LONDON (AP) - Clinical trials of GlaxoSmithKline PLC's experimental multiple sclerosis drug have been halted by the U.S. Food and Drug Administration, the British pharmaceutical company said Wednesday.
|
Cannabis News In Brief |
|
2005.03.22. 20:28 |
|
IACM-Bulletin of 20 March 2005
|
The Netherlands: Comparison between cannabis from coffee |
|
2005.03.22. 20:22 |
|
Researchers of the University of Leiden in cooperation with the
laboratories Farmalyse (Zaandam) and Bactimm (Nijmegen)
compared the quality and price of cannabis sold by coffee shops
and cannabis of the Office of Medicinal Cannabis (OMC) of the
Health Ministry delivered by pharmacies.
|
UK: Survey on the medical use of cannabis |
|
2005.03.22. 20:19 |
|
A questionnaire study of patients who use cannabis for medical
reasons in Britain found 16 per cent do so on the advice of their
doctors. The study was conducted between 1998 and 2002 and
published in the March issue of the International Journal of
Clinical Practice.
|
BBC News - Goat blood drug 'offers MS hope' |
|
2005.03.22. 13:16 |
|
Multiple sclerosis patients are being given hope following trials of a drug made from goats' blood, doctors say.
|
ABC News - The Sum is Equal to the Whole: Individualizing MS Treatment |
|
2005.03.20. 00:14 |
|
Multiple sclerosis (MS) is an insidious disease where destructive lesions in the brain and spinal cord interfere with practically every physical process in the body. No two people have the exact same set of symptoms, which can range from the annoying to the disabling. And that's why many MS specialists are saying that the management of MS symptoms should also vary from person to person.
|
Yahoo! - Multiple Studies Demonstrate Efficacy and Safety of COPAXONE(R) |
|
2005.03.20. 00:11 |
|
COPAXONE(R) Only MS Therapy Available Without Warnings or Precautions for Liver Damage
|
Biospace - Tysabri Withdrawal Prompts Questions About Multiple Sclerosis Drug Target, Notes Pharmaprojects |
|
2005.03.20. 00:07 |
|
LONDON, March 16 /PRNewswire/ -- Pharmaprojects, the leading database tracking pharmaceutical R&D worldwide, highlights a decreasing trend in the development of drugs targeting alpha4beta1 integrin (VLA-4). Following the voluntary withdrawal of Elan's multiple sclerosis drug, Tysabri (natalizumab), from the market and the discontinuation of Antisense Therapeutics' Phase IIa multiple sclerosis trial for ATL-1102, this trend may continue. Should the pharmaceutical industry conclude that alpha1beta4 integrin is no longer a viable drug development target, a further 11 drugs currently in active development could possibly be under threat.
|
Yahoo!/Reuters - Serono scientists find 80 multiple sclerosis genes |
|
2005.03.20. 00:04 |
|
ZURICH (Reuters) - Researchers employed by Swiss-based Serono SA have identified 80 genes involved in multiple sclerosis, forming the basis of a library of potential targets for future treatments of the disease, the firm said on Thursday.
|
Yahoo/AFX - US FDA halts GSK multiple sclerosis drug trials; similarities with Tysabri |
|
2005.03.20. 00:03 |
|
LOS ANGELES (AFX) - The US Food and Drug Administration halted clinical trials for GlaxoSmithKline PLC (LSE: GSK.L - news - msgs) 's investigational drug for multiple sclerosis because it belongs to the same class of drugs as the ill-fated Tysabri.
|
Reuters - FDA, Biogen Warn Over Multiple Sclerosis Drug |
|
2005.03.20. 00:00 |
|
WASHINGTON (Reuters) - Biogen Idec's multiple sclerosis drug Avonex can cause severe liver damage, U.S. regulatory officials and the company warned on Wednesday, the latest in a series of blows to MS patients.
|
The Detroit News - Stem cell therapy knockoffs hit Russia |
|
2005.03.19. 23:55 |
|
People risk health and money paying clinics and beauty salons to treat MS, Parkinson's or wrinkles.
|
FOX News - Blood Test May Spot Early Multiple Sclerosis |
|
2005.03.19. 23:52 |
|
A new blood test may soon allow doctors to detect multiple sclerosis (search) early with a single test rather than the battery of exams now required to definitively diagnose the disease.
|
wistv.com - FDA asks for stronger warning label for multiple sclerosis drug |
|
2005.03.19. 22:12 |
|
March 17, 2005 - Concerns over a drug to treat multiple sclerosis lead to a new warning for patients.
|
MCD - No Comment |
eredeti dátum: 2004.10.05. |
2005.03.15. 11:59 |
|
Valahol Amerikában egy kutatásain dolgozó doktorandusz rágcsálók agysejtjeinek növekedését vizsgálta...
|
Hargita Népe - Méhcsípés a varázsgyógymód? |
eredeti dátum ismeretlen |
2005.03.15. 11:56 |
|
Holland kutatók különleges – bár eléggé fájdalmas – módszert találtak a szklerózis multiplex elleni küzdelemre: méhcsípésekkel kúrálják a betegeket.
|
MCD - A méhcsípés gyógyító hatása |
eredeti dátum ismeretlen |
2005.03.15. 11:52 |
|
A meleg és a virágözön a házi-méheket is előcsalogatta. Ezektől a mézet szorgosan gyűjtögető hártyásszárnyúaktól nem kell tartanunk, ám ha valaki mezítláb rájuk lép vagy tenyerel, megtudhatja, hogy a fullánkjuk milyen fájdalmas szúrást okoz. Az egészséges ember bosszankodhat ezen, bizonyos betegségekben szenvedők ellenben állapotuk javulását remélhetik tőle.
|
CTV - The Pioneers |
|
2005.02.25. 15:09 |
|
A Canadian woman is taking part in a remarkable study to help doctors learn how to stop multiple sclerosis in its tracks. But it's a dangerous and daring protocol that could risk her life.
|
Yahoo - Stopping Catheter-Related Urine Infections with Waterfall D-Mannose |
|
2005.02.25. 15:06 |
|
The product known as 'Waterfall D-Mannose', an extract of fermented larch wood produced by Sweet Cures of York, is proving to be very effective at treating and preventing catheter-related urinary tract infections.
|
IOL - MS can't be cured, but it can be treated |
|
2005.02.24. 23:50 |
|
Multiple sclerosis (MS) was first recorded in South Africa in the late 1950s and today there are about 4 000 MS sufferers in the country.
|
Tysabri trial achieves aim - Elan |
|
2005.02.17. 16:12 |
|
Pharmaceutical companies Elan and Biogen say a late-stage clinical trial of their multiple sclerosis drug Tysabri has achieved its objective.
|
Renovis Announces Initiation of Phase Ia Clinical Study with Investigational Medicine for Multiple Sclerosis |
|
2005.02.17. 01:05 |
|
SOUTH SAN FRANCISCO, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS - News) announced today the initiation of a Phase Ia clinical trial for REN-850, an investigational oral small molecule that is being targeted for the treatment of multiple sclerosis (MS). The objective of this trial is to assess the safety, tolerability and pharmacokinetics of escalating single doses of REN-850 in healthy volunteers. Approximately 45 subjects are planned to participate in the study.
|
Goat Serum Drug Trial |
|
2005.02.14. 11:03 |
|
29.01.04
National media coverage of a potential MS drug treatment derived from goat serum has attracted considerable interest.
|
Canada OKs Marijuana-Based Medicine for MS Relief |
|
2005.02.12. 12:34 |
|
An oral mouth spray derived from the cannabis plant, called Sativex, has received preliminary approval from Canadian health officials as a treatment for neuropathic pain among multiple-sclerosis patients, the Wall Street Journal reported Feb. 8.
|
OSMOND DISCOVERS MIRACLE MS DRUG |
|
2005.02.11. 18:28 |
|
Seventies pop pin-up ALAN OSMOND is championing a new British multiple sclerosis drug based on goat serum, after finding it helped cure many of his symptoms.
|
Young Sibling's Infections Protect Against MS-Study |
|
2005.01.26. 13:11 |
|
CHICAGO (Reuters) - Exposure to a younger sibling's infections during the first six years of life helps the elder child's immune system develop and cuts the risk of multiple sclerosis later on, Australian researchers said on Tuesday.
|
Sclerosis multiplex, apiterápia |
|
2005.01.24. 12:03 |
|
Az Orvos Válaszol 2005;10(1) InforMed
|
Méhcsípéssel a sclerosis multiplex ellen |
|
2005.01.24. 12:01 |
|
Egy 40 éves, sclerosis multiplex miatt deréktól a lábujjáig megbénult nőt heti 36 méhcsípéssel kezelnek.
|
Abnormal levels of hormones enhance multiple sclerosis risk: |
|
2005.01.18. 16:01 |
|
London, Jan 17 : Women with low testosterone levels are twice as likely to be affected by MS than men as abnormal hormone levels play a significant role in how multiple sclerosis develops, a new research suggests.
|
HealthBeat Wrap: Stomach Bug, MS Exercise, Pregnancy And Asthma |
|
2005.01.18. 15:59 |
|
On the HealthBeat Wrap, NewsCenter 5's Heather Unruh had advice on how to survive a nasty stomach bug making the rounds, a new weight-training program for multiple sclerosis patients and new guidelines for pregnant women with asthma.
|
Teva slips on reports of study linking MS drugs to cancer |
|
2005.01.18. 15:53 |
|
Drugmaker Teva Pharmaceuticals lost 3 percent on huge turnover of NIS 89 million yesterday on the Tel Aviv Stock Exchange on rumors of research linking the company's multiple sclerosis treatment Copaxone with breast cancer.
|
Company Reports Positive Trial Of Neurodex For Uncontrollable Laughing And Crying (Pseudobular Affect) In MS |
|
2005.01.17. 13:02 |
|
Avanir Pharmaceuticals announced positive results from a Phase III clinical trial evaluating the safety and effectiveness of the oral drug NeurodexTM (a combination of dextromethorphan and quinidine sulfate) for treating the symptom of “pseudobulbar affect,” a condition involving uncontrollable laughing and/or crying affecting a small proportion of persons with MS...
|
ICS: Cannabis extract cuts urge enuresis in MS patients |
|
2005.01.17. 12:56 |
|
PARIS – Treatment with cannabinoids may help prevent urge incontinence in multiple sclerosis (MS) patients, investigators said at the joint meeting of the International Continence Society and the International UroGynecological Association.
|
Month of birth affects multiple sclerosis risk |
|
2005.01.17. 12:52 |
|
People born in May have an increased risk of developing multiple sclerosis, according to a new study.
|
MS damage repair mechanism found |
|
2005.01.17. 12:50 |
|
Scientists have identified a gene which controls the body's ability to repair the nerve damage inflicted by diseases like multiple sclerosis.
|
Pumping iron helps MS patients |
|
2005.01.17. 12:47 |
|
Sydney - Weight training improves the muscle tone of people with multiple sclerosis and can help them get through daily tasks more easily, researchers in Australia have found.
|
Drug Reduces Frequency of MS Relapses |
|
2005.01.17. 12:43 |
|
FRIDAY, Jan. 14 (HealthDayNews) -- Once-a-month intravenous therapy with the drug Tysabri appears to reduce relapses among people with multiple sclerosis (MS), according to a Rush University Medical Center study.
|
Sex hormones modulate brain damage in multiple sclerosis |
|
2005.01.17. 12:35 |
|
Abnormalities in sex hormone levels may contribute to the damage to brain tissue typical of multiple sclerosis, indicates research in the Journal of Neurology Neurosurgery and Psychiatry.
|
Multiple sclerosis hormone link |
|
2005.01.17. 12:32 |
|
Abnormal hormone levels could play a significant role in how multiple sclerosis develops, research suggests.
|
Elkészült a hírmodul |
|
2005.01.14. 21:51 |
|
Akkor szépen ide fogom gyűjteni az SM hírek eredetijeit. |
|
AJÁNLOM AZ OLDALT
Friss bejegyzések
Friss hozzászólások
Archívum
Tovább…
